My bookmarksSign up free

Commission Regulation (EC) No 2049/2005 Article 6

Conditional fee exemption

Article 6

Without prejudice to Article 5, where an application for marketing authorisation is submitted for a medicinal product on which scientific advice has already been given by the Agency, the fee payable to the Agency for the examination of that application shall be due only if a marketing authorisation is granted.

Read the full instrument → · Read this in context: CHAPTER II — FEE DEFERRALS AND REDUCTIONS →

Other provisions in CHAPTER II — FEE DEFERRALS AND REDUCTIONS

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 6 of Commission Regulation (EC) No 2049/2005 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next